Cargando…
Innate Immune Cells: A Potential and Promising Cell Population for Treating Osteosarcoma
Advanced, recurrent, or metastasized osteosarcomas remain challenging to cure or even alleviate. Therefore, the development of novel therapeutic strategies is urgently needed. Cancer immunotherapy has greatly improved in recent years, with options including adoptive cellular therapy, vaccination, an...
Autores principales: | Wang, Zenan, Wang, Zhan, Li, Binghao, Wang, Shengdong, Chen, Tao, Ye, Zhaoming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6531991/ https://www.ncbi.nlm.nih.gov/pubmed/31156651 http://dx.doi.org/10.3389/fimmu.2019.01114 |
Ejemplares similares
-
Decitabine Enhances Vγ9Vδ2 T Cell-Mediated Cytotoxic Effects on Osteosarcoma Cells via the NKG2DL–NKG2D Axis
por: Wang, Zhan, et al.
Publicado: (2018) -
T-Cell-Based Immunotherapy for Osteosarcoma: Challenges and Opportunities
por: Wang, Zhan, et al.
Publicado: (2016) -
Th9 Cell Differentiation and Its Dual Effects in Tumor Development
por: Chen, Tao, et al.
Publicado: (2020) -
Valproic Acid Combined with Zoledronate Enhance γδ T Cell-Mediated Cytotoxicity against Osteosarcoma Cells via the Accumulation of Mevalonate Pathway Intermediates
por: Wang, Shengdong, et al.
Publicado: (2018) -
Andrographolide induces apoptosis in human osteosarcoma cells via the ROS/JNK pathway
por: Wang, Shengdong, et al.
Publicado: (2020)